DRUG | PHENOTYPE | TARGET | N° | MUTATION | HRM CURVE ASSAY | DNA SEQUENCING |
---|---|---|---|---|---|---|
RIFAMPICIN | Resistant (78) | rpoB | 53 | S531L (TCG → TTG) | mutant | mutant |
14 | D516V (GAC → GTC) | mutant | mutant | |||
2 | H526D (CAC → GAC) | mutant | mutant | |||
1 | Q513L (CAA → CTA) | mutant | mutant | |||
1 | Q513P (CAA → CCA) | mutant | mutant | |||
1 | M515I (ATG → ATA), D516G (GAC → GGC) | mutant | mutant | |||
1 | D516Y (GAC → TAC), N518H (AAC → CAC) | mutant | mutant | |||
1 | H526R (CAC → CGC) | mutant | mutant | |||
1 | H526Y (CAC → TAC) | mutant | mutant | |||
1 | S531F (TCG → TTT) | mutant | mutant | |||
1 | S531W (TCG → TGG) | mutant | mutant | |||
1 | No mutation | wild | wild | |||
Susceptible (89) | 87 | Not sequenced | wild | - | ||
2 | 514 Phe (TTC → TTT) | mutant | wild | |||
ISONIAZID | Resistant (78) | katG | 66 | S315T (AGC → ACC) | mutant | mutant |
1 | S315T (AGC → ACC), C → T (−15) | mutant | mutant | |||
inhA | 10 | C → T (−15) | mutant | mutant | ||
katG,inhA | 1 | No mutation | wild | wild | ||
Susceptible (89) | 87 | Not sequenced | wild | - | ||
2 | No mutation | wild | wild |